Carfilzomib for Treatment of Chronic Graft vs. Host Disease

Trial Profile

Carfilzomib for Treatment of Chronic Graft vs. Host Disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Carfilzomib (Primary)
  • Indications Graft-versus-host disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 29 Dec 2015 Planned initiation date changed from 1 Jul 2015 to 1 Feb 2016, as reported by ClinicalTrials.gov.
    • 14 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top